neuroleptic

(redirected from neuroleptic malignant syndrome)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

Related to neuroleptic malignant syndrome: tardive dyskinesia, Serotonin syndrome

neuroleptic

[‚nu̇r·ō′lep·tik]

(pharmacology)

A drug that is useful in the treatment of mental disorders, especially psychoses.

Pertaining to the actions of such a drug.

References in periodicals archive ?

Neuroleptic malignant syndrome. Med Clin North Am 1993; 77(1): 185-202.

ELECTROCONVULSIVE THERAPY (ECT) FOR THE MANAGEMENT OF NEUROLEPTIC MALIGNANT SYNDROME (NMS) IN ADULTS

Patients with neuroleptic malignant syndrome histories: What happens when they are rehospitalized?

Olanzapine-induced neuroleptic malignant syndrome

Neuroleptic malignant syndrome in children and adolescents.

Antipsychotic Drugs Rechallenge in Multi-antipsychotic Drug Induced Atypical Neuroleptic Malignant Syndrome: A Case of Cotard's Syndrome/Coklu Antipsikotik Ilac Kullanimi ile Tetiklenen Atipik Noroleptik Malign Sendromda Antipsikotik Ilac Baslama Guclukleri: Cotard Sendromu Olgusu

(1.) Berman, B.D., Neuroleptic malignant syndrome: a review for neurohospitalists.

Neuroleptic Malignant Syndrome. Diagnostic challenges

Lee, "Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome," Journal of Clinical Psychopharmacology, vol.

Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review

Raguram, "The neuroleptic malignant syndrome: an Indian experience," Comprehensive Psychiatry, vol.

Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine

Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.

Neuroleptic malignant syndrome associated with lithium toxicity

Keywords: Neuroleptic Malignant Syndrome, Electroconvulsive therapy.

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989;146:717-25.

An atypical presentation of neuroleptic malignant syndrome coexisting with Staphylococcus Pneumonia: a diagnostic challenge

In recent years, CK elevations related to use of atypical antipsychotics have been reported in several case studies in the absence of neuroleptic malignant syndrome. Two of them were about rhabdomyolysis due to quetiapine overdose (6,7).

Massive creatine kinase and hepatic enzyme elevation due to quetiapine and valproic acid treatment: a case report/Ketiapin ve valproik asit tedavisine bagli olarak gelisen masif kreatin kinaz ve karaciger enzim yuksekligi: bir olgu sunumu

Neuroleptic malignant syndrome: a complication of neuroleptics and cocaine abuse.

How to recognize a patient who's high on "bath salts": forget about a routine drug screen; it won't help. Here's how these patients will present and how best to care for them

A diagnosis of neuroleptic malignant syndrome related to haloperidol (day 2; cumulative dose: 10 mg) was considered because of the patient's rigidity, fever, and rhabdomyolysis.